# Immix Biopharma, Inc. (IMMX)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/IMMX/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -21.64M | $ -21.62M | $ 1.00M | $ 228.92M |
| 2025 | $ 0 | $ -30.14M | $ -25.25M | $ 1.07M | $ 93.80M |
| 2024 | $ 0 | $ -22.72M | $ -16.58M | $ 1.07M | $ 13.25M |
| 2023 | $ 0 | $ -16.68M | $ -12.35M | $ 0 | $ 16.41M |
| 2022 | $ 0 | $ -9.19M | $ -8.28M | $ 0 | $ 13.16M |
| 2021 | $ 0 | $ -28.98M | $ -1.89M | $ 50.0K | $ 17.99M |
| 2020 | $ 0 | $ -1.46M | $ -515.6K | $ 4.10M | $ -4.73M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.00 |
| Liabilities / Eq | 0.04 |
| Current Ratio | 25.13 |

## Other views

- [Metrics](https://sponda.capital/en/IMMX.md)
- [Charts](https://sponda.capital/en/IMMX/charts.md)
- [Compare](https://sponda.capital/en/IMMX/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-30.